CD274 and hepatocellular carcinoma: Additionally, TAMs are key players in the failure of immune checkpoint blockade therapy (i.e., anti-PD-L1) in HCC, as they secrete the chemokine CCL20, a potent chemoattractant of CCR6+FoxP3+ regulatory T cells (Tregs) [158].